Contact

About Us

Acelot is a development stage biopharmaceutical company focused on therapies for Alzheimer’s Disease and central nervous system disorders. Our revolutionary JPS technology allows us to develop on-target therapies with a high degree of therapeutic predictability.

Acelot's drug discovery pipeline comprises several compound families for Alzheimer's disease. These compounds span a variety of mechanisms-of-action and have been validated in a number of in-vitro assays to date.

Navigation

• Front Page
• Company
• Team
• Current Pipeline
• Oligomer Blockers
• LXR Agonists
• Technology
• Acelot Online Privacy Policy
• Contact

Latest News

Grant for LXR Project

Acelot has been awarded a prestigious SBIR Grant from…

Patent Granted

U.S. patent 9,218,460 on the JPS method has been…

Contact Info